Back to School: How biopharma can reboot drug development. Access exclusive analysis here

GLGC acquires MLNM technologies

Gene Logic (GLGC) acquired a drug development technology program and an associated research team from Millennium (MLNM) to build a drug development services business. GLGC acquired

Read the full 268 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE